1990 - 2019年中国精神和物质使用障碍负担
Burden of Mental and Substance Use Disorders - China, 1990-2019.
作者信息
Ma Chao, Yu Shicheng, Huang Yueqin, Liu Zhaorui, Wang Qiqi, Chen Hongguang, Zhang Tingting, Zhou Maigeng
机构信息
Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.
Office of Epidemiology, Chinese Center for Disease Control and Prevention, Beijing, China.
出版信息
China CDC Wkly. 2020 Oct 9;2(41):804-809. doi: 10.46234/ccdcw2020.219.
Mental and substance use disorders have notable contributions to the disease burden in China. In China, mental disorders and substance use disorders accounted for 20.29 million and 5.76 million disability-adjusted life years (DALYs) in 2019, respectively; depressive disorders were the leading cause of DALYs. For mental disorders, the numbers of DALYs increased 12.06% from 2000 to 2019 while the standardized rates declined 5.24%; for substance use disorders, both the numbers and standardized rates of DALYs decreased 8.52% and 18.52%, respectively. Mental and substance use disorders pose a challenge to the healthcare system in China. The government should take action and decrease the associated burden of disease.
精神和物质使用障碍对中国的疾病负担有显著影响。在中国，2019年精神障碍和物质使用障碍分别导致2029万和576万伤残调整生命年（DALYs）；抑郁症是导致伤残调整生命年的主要原因。对于精神障碍，2000年至2019年伤残调整生命年数量增加了12.06%，而标准化率下降了5.24%；对于物质使用障碍，伤残调整生命年的数量和标准化率分别下降了8.52%和18.52%。精神和物质使用障碍给中国的医疗保健系统带来了挑战。政府应采取行动，减轻相关疾病负担。
Zotero 插件